First Line Treatments For Common Musculoskeletal Conditions: Establishing Effectiveness And Cost-effectiveness
Funder
National Health and Medical Research Council
Funding Amount
$452,583.00
Summary
Dr Christine Lin is an outstanding young researcher whose research focuses on investigating the effectiveness and cost-effectiveness (value-for-money) of treatments for common musculoskeletal conditions. These conditions, such as back pain and fracture, are a major cause of disability in Australia and abroad. Dr Lin will lead a series of large clinical studies with an aim to improve patient outcomes while minimising the economic burden on the individual, health system and society.
Improving The Prevention And Clinical Management Of Infectious Diseases
Funder
National Health and Medical Research Council
Funding Amount
$236,146.00
Summary
Modern methods of analysis employ complex tools that are not always available or easily understood by doctors making decisions. The dosing of antibiotics is usually constant, even though known factors influence its effectiveness. Similarly, how effective vaccines are can be estimated from routinely available data. This project will develop tools and strategies to assist doctors and public health authorities make the best decisions by improving the analysis of existing data.
Connecting The Dots: Novel Social Media Technologies For Long-term Functional Recovery In First Episode Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$432,528.00
Summary
The aim of this program of research is to evaluate the effectiveness of innovative online social media and mobile-based interventions purposely designed to improve long-term recovery in youth mental health (i.e., early psychosis and youth depression). These pioneering interventions have been designed by a large multidisciplinary team through the integration of cutting-edge social media technologies, new psychological models and strong consumer-youth participation.
Using Health Economics To Improve Access To Health Care In Under-served Populations
Funder
National Health and Medical Research Council
Funding Amount
$476,728.00
Summary
Many health care interventions shown to be effective and cost-effective under controlled conditions are consistently under-utilised or mis-used in resource poor settings, especially by the most deprived groups. Over the next 4 years I will establish a program of health economics and health services research to improve the delivery and financing of health care interventions to ensure everyone reaps the benefits of medical science and health technologies and not just those who can afford it.
Alcohol-related harm is a major contributor to the total burden of disease and social problems experienced both globally and in Australia. Considerable burden is placed on health and policing sectors and at substantial financial cost. This project will significantly improve Australian capacity to monitor alcohol related harms at local, state and national levels, enhance the underlying epidemiology and understanding of relations between alcohol and harm and enable reliable and timely evaluation o ....Alcohol-related harm is a major contributor to the total burden of disease and social problems experienced both globally and in Australia. Considerable burden is placed on health and policing sectors and at substantial financial cost. This project will significantly improve Australian capacity to monitor alcohol related harms at local, state and national levels, enhance the underlying epidemiology and understanding of relations between alcohol and harm and enable reliable and timely evaluation of alcohol policy.Read moreRead less
Investigatin The Causes Of Failed Efferocytosis In COPD-emphysema With A View To Identifying Novel Theraputic Targets
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
COPD is a leading cause of death. Smoking is the major cause of COPD and many sufferers are left with permanent damage and need ongoing treatment even after smoking cessation. Current treatments for COPD generally have limited efficacy. The project will identify the reason for the large number of dying cells and defective clearance of these cells that we have identified in the airways in COPD and study novel treatments that we hope will improve the health and well being of those with COPD.
The mortality rate from community-acquired pneumonia has not improved over the past four decades. New pulmonary infectious diseases such as due to non tuberculous mycobacteria are causing increasing problems and bronchiectasis is responsible for an ever increasing mortality, morbidity and economic burden on our health system. This grant will support Professor Waterer in continuing to reduce the personal and society burden of pulmonary infections.